TRT for fatigue and low libido: what the evidence actually shows

What's this video probably claiming?

Based on the caption, this creator is pitching testosterone replacement therapy as a broad fix for fatigue, low libido, and mood changes. The checklist format, the word "unlock," and the truncated "Increase" bullet all follow a familiar TikTok TRT script: you're tired, you're not yourself, and testosterone is the answer. The hashtags lean into #menshealth optimization culture, which tends to frame TRT as a lifestyle upgrade rather than a medical treatment for a diagnosed condition. Expect the video to cite energy, muscle, mood, and sex drive as benefits, probably without much mention of baseline labs, diagnostic criteria, or the difference between clinical hypogonadism and garden-variety burnout. The framing of "unlock your potential" is aspirational marketing language, not clinical language, and that gap matters a lot when we're talking about a controlled substance with real physiological effects.

What does the science actually show?

The evidence for TRT in men with confirmed hypogonadism, meaning two morning total testosterone readings below 300 ng/dL with symptoms, is reasonably solid for certain outcomes. The Testosterone Trials (Snyder et al., 2016, New England Journal of Medicine) followed 790 men aged 65 and older with low testosterone and found modest improvements in sexual function and some mood measures, but mixed results for energy and physical function. A 2023 meta-analysis by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism found TRT in hypogonadal men improved lean mass, reduced fat mass, and improved sexual desire, but effect sizes were often modest and varied widely by baseline testosterone level. The problem is most social media TRT content doesn't acknowledge the diagnostic threshold. Studies consistently show minimal benefit in men with testosterone in the low-normal range, roughly 300-400 ng/dL, which is exactly where a lot of "optimization" patients sit.

Where does the social media noise diverge from clinical reality?

The biggest divergence is the diagnosis problem. Fatigue, low mood, and reduced libido are symptoms of dozens of conditions: sleep apnea, depression, thyroid dysfunction, anemia, and plain exhaustion. A TikTok checklist cannot distinguish hypogonadism from any of them. Prescribing TRT without confirmed low testosterone and symptom correlation doesn't just waste money. It suppresses endogenous testosterone production by shutting down the hypothalamic-pituitary-gonadal axis, sometimes permanently in younger men. The 2018 AUA guidelines explicitly state TRT is contraindicated in men who want to preserve fertility because exogenous testosterone suppresses sperm production, often to zero. The cardiovascular risk story is also more complicated than these videos imply. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found no significant increase in major cardiovascular events in a selected population, but this doesn't clear the risk profile for younger men using supraphysiologic doses or men with untreated cardiovascular risk factors.

What should you actually know?

TRT is a legitimate medical treatment for a specific diagnosed condition. It is not a general wellness tool, and the gap between those two things is where patients get hurt. If you're fatigued and your testosterone comes back at 380 ng/dL, TRT is unlikely to fix the fatigue and will likely suppress your natural production for the duration of treatment. Baseline labs should include at minimum two morning total testosterone levels, LH, FSH, prolactin, SHBG, hematocrit, and PSA in older men. The Endocrine Society's 2018 clinical practice guidelines recommend treating only men with consistently low testosterone and unambiguous symptoms. Once you start TRT, stopping is not simple. Testicular atrophy, infertility, and prolonged hypogonadism post-cessation are real documented outcomes. Polycythemia, elevated hematocrit that increases clotting risk, is a common side effect requiring monitoring. Anyone selling TRT through an "unlock your potential" frame without discussing these trade-offs is doing their audience a disservice.